Sponsor or institution
Clinical trials and research at Kind Pharmaceuticals LLC
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Kind Pharmaceuticals LLC that are recruiting, at sites in 2 countries (most in China (4), United States (1)). By phase: Phase 2 (2), Phase 3 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| AND017 for anemia in people on dialysis for chronic kidney disease | Phase 3 | Shanghai | Recruiting | Mar 27, 2026 |
| AND017 for anemia in people with chronic kidney disease who are not on dialysis. | Phase 3 | Beijing, Beijing Municipality | Recruiting | Mar 23, 2026 |
| AND017 for anemia in lower-risk myelodysplastic syndromes | Phase 2 | Hangzhou, Zhejiang | Recruiting | Mar 12, 2024 |
| Treatment of β-thalassemia with AND017 | Phase 2 | Guangzhou, Guangdong and 4 other locations | Recruiting | Mar 8, 2024 |
| Evaluating AND019 in Women with Advanced Breast Cancer | Phase 1 | Nashville, Tennessee | Recruiting | Jan 12, 2022 |
All recruiting trials (5)
-
AND017 for anemia in people on dialysis for chronic kidney disease
This trial will test whether AND017 capsules can increase hemoglobin and be safe in adults on dialysis for end-stage kidney disease who have anemia, compared with standard ESA treatment.
-
AND017 for anemia in people with chronic kidney disease who are not on dialysis.
This Phase 3 study will test whether AND017 raises hemoglobin and is safe in adults with anemia from non-dialysis-dependent chronic kidney disease, compared with standard ESA treatment.
-
AND017 for anemia in lower-risk myelodysplastic syndromes
This trial will try AND017 to see if it improves anemia in people with lower-risk myelodysplastic syndromes who are non-transfusion-dependent or have a low transfusion burden.
-
Treatment of β-thalassemia with AND017
This study is testing a new drug called AND017 to see if it can help people with β-thalassemia feel better compared to standard treatments.
-
Evaluating AND019 in Women with Advanced Breast Cancer
This study is testing a new oral medication called AND019 to see if it is safe and effective for postmenopausal women with advanced breast cancer who haven't had success with other treatments.
Quick answers
How many clinical trials run by Kind Pharmaceuticals LLC are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (4 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.